Transient Hyperammonemia Due to L -Asparaginase Therapy in Children with Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

REFERENCES

• Armstrong JK, Hempel G, Koling S, Antibody against poly(ethylene glycol) adversely affects PEG asparaginase therapy in acute lymphoblastic leukemia patients. Cancer. 2007;110:103–111.
   PubMed Web of Science ®Google Scholar
• Asselin B, Lorenzon M, Whitin J, Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor. Cancer Res. 1991;51:6568–6573.
   PubMed Web of Science ®Google Scholar
• Badizadegan K, Perez-Atayde A. Focal glycogenosis of the liver in disorder of ureagenesis: its occurrence and diagnostic significance. Hepatology. 1997;26:365–373.
   Google Scholar
• Bodmer M, Sulz M, Stadlmann S, Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L- asparaginase. Digestion. 2006;74:28–32.
   PubMed Web of Science ®Google Scholar
• Boos J, Werber G, Ahlke E, Monitoring of asparaginase activity and asparaginase levels in children on different asparaginase preparations. Eur J Cancer. 1996;32A:1544–1550.
   PubMed Web of Science ®Google Scholar
• Desai N, Amylon M, Schwenn MR, Outcome of advanced stage (III–IV) lymphoblastic Non-Hodgkin's lymphoma—a Pediatric Oncology Group (POG) study. Med Pediatr Oncol. 1997;29:356 (Abstract O-140).
   Google Scholar
• Jensen SA, Almdal TP, Vilstrup H. Acute in vivo effects of low ethanol concentrations on the capacity of urea synthesis in rats. Alcohol Clin Exp Res. 1991;15:90–93.
   Google Scholar
• Kohn MC, Tohmaz AS, Giroux KJ, Robustness of metaNet graph models: predicting control of urea production in humans. Biosystems. 2002;65:61–78.
   Google Scholar
• Laterza OF, Gerhardt G, Sokoll LJ. Measurement of plasma ammonia is affected in patients receiving asparaginase therapy. Clin Chem. 2003;49:1710–1711.
   Google Scholar
• Maier KP, Volk B, Hoppe-Seyler G, Gerok W. Urea-cycle enzymes in normal liver and in patients with alcoholic hepatitis. Eur J Clin Invest. 1974;4:193–195.
   Google Scholar
• Müller HJ, Boss J. Use of L-asparaginase in childhood all. Crit Rev Oncol Hematol. 1998;28:97–113.
   PubMed Web of Science ®Google Scholar
• Müller HJ, Löning L, Horn A, Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in re-induction according to the ALL/NHL-BFM 95 protocols. Br J Haematol. 2000;110:379–384.
   PubMed Web of Science ®Google Scholar
• Muss HB, Spell N, Scudiery D, A phase II trial of PEG and L asparaginase in the treatment of non hodgins lymphoma. Invest New Drugs. 1990;8:125–130.
   PubMed Web of Science ®Google Scholar
• Maestri NE, Brusilow SW, Clissold DB, Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med. 1996;335:855–859.
   PubMed Web of Science ®Google Scholar
• Nielssen SS, Grofte T, Tygstrup N, Cirrhosis and endotoxin decrease urea synthesis in rats. Hepatol Res. 2007;37:540–547.
   Google Scholar
• Gordon N. Ornithine transcarbamylase deficiency: a urea cycle defect. Eur J Paediatr Neurol. 2003;7:115–121.
   PubMed Web of Science ®Google Scholar
• Oechsner M, Steen C, Stürenburg HJ, Kohlschütter A. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiaty. 1998;64:680–682.
   PubMed Web of Science ®Google Scholar
• Oettgen HF, Stephenson PA, Schwartz MK, Toxicity of E. coli L-asparaginase in man. Cancer. 1970;25:253–278.
   PubMedGoogle Scholar
• Otten J, Suciu S, Lutz P, The importance of L-asparaginase in the treatment of acute lymphoblastic leukemia (ALL) in children: results of the EORTC 58881 randomized phase III trial showing greater efficiency of Escherichia coli (E. coli) as compared to Erwinia (Erw) A’ase. Blood. 1996;88(Suppl 1/1):669A.
   Google Scholar
• San Pietro A, Rittenberg D. A study of the rate of proetin synthesis in humans. II. Measurement of the metabolic pool and the rate of protein synthesis. J Biol Chem. 1953;201:457–473.
   PubMed Web of Science ®Google Scholar
• Pratt CB, Roberts D, Shanks E, Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia. Cancer Res. 1973;33:2020–2025.
   PubMed Web of Science ®Google Scholar
• Rimbaux S, Hommet C, Perrier D, Adult onset ornithine transcarbamylase deficiency: an unusual cause of semantic disorders. J Neurol Psychiatry. 2004;75:1073–1075.
   Google Scholar
• del Rosario M, Werlin SL, Lauer SJ. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate. J Clin Gastroenterol. 1997;25:682–684.
   Google Scholar
• Janka-Schaub G. CO ALL 06-97, clinical study protocol. 1997:1–143.
   Google Scholar
• Janka-Schaub G. CO ALL 07-03, clinical study protocol. 2003:1–145.
   Google Scholar
• Schrappe M, Müller HJ, Löning L, Clinical experience with PEG-asparaginase in children with ALL: a pilot study in reinduction phase of trial ALL-BFM 95. Ann Hematol Suppl. 1999;78:20–64.
   Google Scholar
• Brusilow SW, Horwich AL. Urea Cycle Enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.): The Metabolic and Molecular Bases of Inherited Disease, 8th edition, New York: McGrawHill, 2001.
   Google Scholar
• Steiner M, Attarbaschi A, Kastner U, Distinct fluctations of ammonia levels during asparaginase therapy for childhood acute leukemia. Pediatr Blood Cancer. 2007;49:640–642.
   PubMed Web of Science ®Google Scholar
• Vilstrup H. Synthesis of urea after stimulation with amino acids: relation to liver function. Gut. 1980;21:990–995.
   PubMed Web of Science ®Google Scholar
• Xu SR, Yao EG, Dong ZR, Plasma ammonia in patients with acute leukemia. Chin Med J (Engl). 1992;105:713–716.
   PubMed Web of Science ®Google Scholar